By continuing to use Symptoma®, you confirm you accept the cookies. More on
460001 to 460100 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Echo 9 virus antibody status after an epidemic period and the possible teratogenic effect of the infection.
Developmental risks associated with use of psychoactive drugs during pregnancy are largely unknown. Authors' reply.
Developmental risks associated with use of psychoactive drugs during pregnancy are largely unknown.
Adverse drug reactions induced by valproic acid.
THE MECHANISM OF VITAMIN A INDUCED TERATOGENESIS.
Influence of infection during pregnancy on fetal development.
[TOXIC AND TERATOGENIC EFFECTS OF THALIDOMIDE ON A RABBIT FETUS].
Testicular teratomas. I. Demonstration of teratogenesis by metamorphosis of multipotential cells.
TERATOGENIC EFFECTS OF HYPOGLYCEMIC TREATMENTS IN INBRED STRAINS OF MICE.
Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models.
Depletion of retinoic acid receptors initiates a novel positive feedback mechanism that promotes teratogenic increases in retinoic acid.
[TERATOGENIC ACTION OF TRIPARANOL IN ANIMALS].
Teratogenic effects of Asian influenza.
Sick Building Syndrome
Neoplasms, Connective and Soft Tissue
Parry-Romberg syndrome with migraine and intracranial aneurysm.
Parry-Romberg syndrome with a clinically silent white matter lesion.
Parry Romberg syndrome and linear scleroderma in coup de sabre mimicking Rasmussen encephalitis.
Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea.
Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome.
Progressive intracranial aneurysmal disease in a child with progressive hemifacial atrophy (Parry-Romberg disease): case report.
Progressive hemifacial atrophy (Parry-Romberg disease).
Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre.
Masticatory spasm in facial hemiatrophy.
Influence of unilateral masseter muscle atrophy on craniofacial morphology in growing rabbits.
FUCHS' HETEROCHROMIC CYCLITIS ASSOCIATED WITH FACIAL HEMIATROPHY (SCLERODERMA EN COUP DE SABRE).
Chess masters show a hallmark of face processing with chess.
Progressive hemifacial atrophy (Parry-Romberg syndrome) report with review of genetics and nosology.
Clinical and ultrastructural studies of Romberg's hemifacial atrophy.
Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients.
Progressive sensory loss in familial dysautonomia.
Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome).
En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells.
Venereal Tumors, Veterinary
Cervical Rib Syndrome
Reply: To PMID 23121116.
Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients.
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.
Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.
Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate.
Evgeny M Krupitsky
Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.
Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Hereditary angioedema: an update on available therapeutic options.
Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.
The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?
Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients.
Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies.
Cross-talk between the complement and the kinin system in vascular permeability.
Angioedema due to C1 inhibitor deficiency in 2010.
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.
Panniculitis, Lupus Erythematosus
The pathology of gestational trophoblastic disease: recent advances.
Primary chemotherapy of nonmetastatic trophoblastic disease in women.
Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.
Hyperglycosylated hCG, a review.
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions.
Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Gestational trophoblastic disease.
First line chemotherapy in low risk gestational trophoblastic neoplasia.
Neoplasia with use of intrauterine devices.
Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets.
Gestational trophoblastic disease.
Burning Sensation, Pulmonary Fibrosis, weight loss, chest x-ray abnormal, fever, loss of appetite
Epidemiology and aetiology of gestational trophoblastic diseases.
Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia.
Sarcoma, Small Cell
The classification, functions and clinical use of different isoforms of HCG.
Mixed Tumor, Mesodermal
Lymphoma of the cavernous sinus mimicking Tolosa-Hunt syndrome in a child.